# Michael Har-Noy

> Michael Har-Noy is a bioengineer and company founder whose career spans research, manufacturing and business leadership. He founded Immunovative Therapies in Israel in 2004 and Mirror Biologics, Inc. in 2018. His public record includes international operations, proprietary equipment development, executive recruitment and disputes over corporate governance. An April 2025 authored article identified him as Mirror’s Chief Medical Officer; an August 2026 court order identified him as its founder and former director.

- **Role:** Founder of Mirror Biologics, Inc.; Chief Medical Officer documented April 2025
- **Organizations:** Mirror Biologics, Inc., Mirror Biologics, Ltd., Immunovative Therapies, Ltd., Immunovative Clinical Research, Inc., Hadassah-Hebrew University Medical Center
- **Education:** PhD in bioengineering, documented in a 2024 federal decision, Attended an MD-PhD program; completion is not specified in the conference biography, Rush University Medical School, Postdoctoral training, University of Minnesota, Research fellowship, Harvard Medical School
- **Known for:** Founded Immunovative Therapies in 2004 and Mirror Biologics, Inc. in 2018., A 2024 federal decision described him as sole inventor of over 200 patented technologies., Listed in The BrandLaureate’s 2019 Brand Icon Leadership roster.

## Career timeline

- **2004** — Founded Immunovative Therapies at the Misgav incubator after moving from San Diego to Israel.
- **2006** — Immunovative left the incubator in May and raised $1.2 million from angel investors, as reported in 2007.
- **2009** — Immunovative Clinical Research, Inc. was established as a wholly owned subsidiary in February.
- **2011** — Novo Energies announced a memorandum of understanding to acquire Immunovative Clinical Research; this was a proposed transaction.
- **2018** — Mirror Biologics, Inc. was incorporated in Delaware on November 5.
- **2019** — Scheduled to present at Biotech Showcase in San Francisco; described dividing his time among Jerusalem, Phoenix and Thailand.
- **2021** — Assigned his patent rights to Mirror on August 20, according to a subsequent federal decision.
- **2024** — Identified as founder and acting CEO in the announcement of Elizabeth Adkins Czerepak’s appointment as CFO and VP Corporate Development.
- **2025** — An April 21 authored article identified him as Mirror’s Chief Medical Officer.
- **2026** — An August 11 Delaware order identified him as founder and former director of Mirror USA and granted entitlement to advancement of legal expenses.

## Achievements

- Founded Immunovative Therapies in 2004 and Mirror Biologics, Inc. in 2018.
- A 2024 federal decision described him as sole inventor of over 200 patented technologies.
- Listed in The BrandLaureate’s 2019 Brand Icon Leadership roster.
- His executive biography credits him with a first-place undergraduate research award from Beta Beta Beta.

## Latest updates

- **2026-08** — On August 11, the Delaware Court of Chancery held him entitled to advancement of legal fees and expenses in connection with Israeli litigation, plus fees for enforcing that right and prejudgment interest; the decision did not determine the underlying misconduct allegations.
- **2026-05** — A May 27 publication listed his affiliation as Immunovative Therapies, Ltd., Jerusalem.
- **2025-04** — His April 21 article on ADRES identified him as Chief Medical Officer of Mirror Biologics.

## Links

- Website: https://about.me/michaelharnoy
- LinkedIn: https://www.linkedin.com/in/dr-michael-har-noy-7647291/

---

Profile page: https://yespress.io/michael-har-noy
Published by YesPress — https://yespress.io
Last updated: 2026-10-11